Latest news for PhotoCure (OTC:PHCUF) Stock

PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products specialty pharmaceutical companies. Its technology platform is focused on the field of photodynamic diagnosis and treatment of cancer. It has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, and the United States.

PhotoCure ASA

Photocure ASA (PHCUF) has released an update. Photocure ASA reported Hexvix/Cysview revenues of NOK 122.4 million in Q2 2024, marking a 6% increase...

Photocure ASA Reports Growth and Optimistic Outlook

Photocure ASA reports Q2 results

Photocure ASA (PHCUF) has released an update. Photocure ASA has announced that its partner, Asieris Pharmaceuticals, will present Phase III clinica...

Photocure Announces Cevira's Successful Phase III Results

Photocure ASA (PHCUF) has released an update. Photocure ASA, known as the Bladder Cancer Company, has partnered with Equity Pharmaceuticals to laun...

Photocure Expands Bladder Cancer Treatment in South Africa

Photocure ASA (PHCUF) has released an update. Photocure ASA's partner Asieris Pharmaceuticals has announced successful Phase III trial results for ...

Promising Trial Results for Cervical Lesion Treatment

Photocure ASA (PHCUF) has released an update. Photocure ASA is set to release its third quarter 2024 financial results on November 13, with a live ...

Photocure ASA to Announce Q3 Financial Results

Photocure ASA (PHCUF) has released an update. Photocure ASA reported a 12% increase in Hexvix/Cysview revenues to NOK 120.1 million in Q3 2024, wit...

Photocure ASA Sees Strong Q3 Revenue Growth

Photocure ASA reports Q3 results

Photocure ASA (PHCUF) has released an update. Board member Ghizlane Tagmouti of Photocure ASA has recently acquired 20,218 shares at an average pri...

Photocure Board Member Acquires Shares, Boosting Confidence

Photocure ASA (PHCUF) has released an update. Photocure ASA has initiated a share buyback program to repurchase up to 300,000 shares for a maximum ...

Comments

PhotoCure

News

Latest news for PhotoCure (OTC:PHCUF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga